Class information for:
Level 1: VANDETANIB//RAMUCIRUMAB//CEDIRANIB

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY 2934640
279 3       ANGIOGENESIS//LYMPHANGIOGENESIS//VEGF 43269
379 2             LYMPHANGIOGENESIS//ANGIOGENESIS//VEGF 17562
7485 1                   VANDETANIB//RAMUCIRUMAB//CEDIRANIB 1387

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 VANDETANIB authKW 497252 4% 36% 61
2 RAMUCIRUMAB authKW 449278 3% 43% 46
3 CEDIRANIB authKW 309220 3% 39% 35
4 NINTEDANIB authKW 304909 3% 36% 37
5 BEVACIZUMAB authKW 252715 16% 5% 216
6 BIBF 1120 authKW 178123 1% 56% 14
7 VEGFR authKW 176468 4% 16% 49
8 AZD2171 authKW 163584 1% 60% 12
9 VEGFR2 authKW 140563 5% 9% 67
10 ZD6474 authKW 136779 1% 35% 17

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 19667 61% 0% 849
2 Chemistry, Medicinal 1922 12% 0% 161
3 Respiratory System 1342 9% 0% 120
4 Pharmacology & Pharmacy 1196 19% 0% 264
5 Chemistry, Organic 123 6% 0% 82
6 Medicine, Research & Experimental 39 3% 0% 45
7 Hematology 29 2% 0% 31
8 Biotechnology & Applied Microbiology 17 3% 0% 43
9 Cell Biology 2 3% 0% 40
10 Biochemistry & Molecular Biology 2 6% 0% 87

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 DIPARTIMENTO MED CHIRURG INTERNIST CLIN 45443 0% 100% 2
2 SECT MR DEV 45443 0% 100% 2
3 TRANSLAT CLIN DEV 45443 0% 100% 2
4 PHARMACOL SAFETY EVALUAT TIBETAN MED QI 34079 0% 50% 3
5 SEVERANCE INT HLTH CARE 30294 0% 67% 2
6 THORAC HEAD NECK MED ONCOL CANC BIOL 30294 0% 67% 2
7 MED ONCOL 25103 17% 0% 235
8 THORAC ONCOL 23266 3% 2% 48
9 ADV TECHNOL TRANSLAT SCI 22721 0% 100% 1
10 AERODIGEST THORAC TUMOR PROGRAM 22721 0% 100% 1

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 JOURNAL OF THORACIC ONCOLOGY 27540 4% 2% 58
2 CLINICAL LUNG CANCER 22478 2% 3% 29
3 TARGETED ONCOLOGY 7247 1% 3% 12
4 LUNG CANCER 6052 3% 1% 35
5 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 6029 2% 1% 24
6 INVESTIGATIONAL NEW DRUGS 5881 2% 1% 26
7 JOURNAL OF CLINICAL ONCOLOGY 4733 4% 0% 59
8 CANCER CHEMOTHERAPY AND PHARMACOLOGY 4097 3% 0% 37
9 CLINICAL CANCER RESEARCH 3948 4% 0% 52
10 ONCOLOGIST 3875 1% 1% 20

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 VANDETANIB 497252 4% 36% 61 Search VANDETANIB Search VANDETANIB
2 RAMUCIRUMAB 449278 3% 43% 46 Search RAMUCIRUMAB Search RAMUCIRUMAB
3 CEDIRANIB 309220 3% 39% 35 Search CEDIRANIB Search CEDIRANIB
4 NINTEDANIB 304909 3% 36% 37 Search NINTEDANIB Search NINTEDANIB
5 BEVACIZUMAB 252715 16% 5% 216 Search BEVACIZUMAB Search BEVACIZUMAB
6 BIBF 1120 178123 1% 56% 14 Search BIBF+1120 Search BIBF+1120
7 VEGFR 176468 4% 16% 49 Search VEGFR Search VEGFR
8 AZD2171 163584 1% 60% 12 Search AZD2171 Search AZD2171
9 VEGFR2 140563 5% 9% 67 Search VEGFR2 Search VEGFR2
10 ZD6474 136779 1% 35% 17 Search ZD6474 Search ZD6474

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 17263 BEVACIZUMAB//METASTATIC BREAST CANCER//HER2 NEGATIVE
2 1966 VEGF//VASCULAR ENDOTHELIAL GROWTH FACTOR//FLT 1
3 14959 BEVACIZUMAB//OVARIAN CANCER//GYNECOL ONCOL
4 29828 REGORAFENIB//FRUQUINTINIB//N DESETHYL SUNITINIB
5 747 SUNITINIB//METASTATIC RENAL CELL CARCINOMA//RENAL CELL CARCINOMA
6 38034 TSU 68//SU006668//MCA RH7777
7 31888 ALFA 2B//ANTI TYRP 1 GP75//BLOOD PERFUSION ESTIMATES
8 24732 PODOPHYLLOTOXIN ACETATE//SERV NEUROSURG NEUROONCOL//LARN PMR
9 11599 ANAPLASTIC THYROID CARCINOMA//ANAPLASTIC THYROID CANCER//LENVATINIB
10 826 NON SMALL CELL LUNG CANCER//VINORELBINE//GEMCITABINE

Go to start page